Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

6.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
6.0K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

97
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
97
Enzyme Inhibition01:30

Enzyme Inhibition

79.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the high urea metabolic capacity of indigenous Schizosaccharomyces japonicus during alcoholic fermentation.

Food microbiology·2026
Same author

L-type pyocins inhibit the BAM complex to kill without cell entry.

Nature communications·2026
Same author

Structural basis for independent pore function of Vpb4 from Bacillus thuringiensis.

Nature communications·2026
Same author

[Advances in research on neuroelectrophysiological characteristics of post-stroke cognitive impairment based on quantitative electroencephalography and acupuncture interventions].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same author

[High-throughput fluorescence-activated droplet sorting of polyethylene terephthalate hydrolases based on fluorescent nanoparticle biosensors].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026
Same author

Cluster analysis of Model for End-stage Liver Disease and European System for Cardiac Operative Risk Evaluation for predicting operative mortality after concomitant tricuspid valve surgery.

JTCVS structural and endovascular·2026

Related Experiment Video

Updated: Sep 16, 2025

Detection of the pH-dependent Activity of Escherichia coli Chaperone HdeB In Vitro and In Vivo
08:32

Detection of the pH-dependent Activity of Escherichia coli Chaperone HdeB In Vitro and In Vivo

Published on: October 23, 2016

10.7K

Inhibiting heme piracy by pathogenic Escherichia coli using de novo-designed proteins.

Daniel R Fox1,2,3, Kazem Asadollahi3, Imogen Samuels3

  • 1Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.

Nature Communications
|July 9, 2025
PubMed
Summary

Researchers designed novel protein binders using AI to block bacterial iron uptake. These binders inhibit pathogenic E. coli growth by preventing heme extraction from hemoglobin, offering a new therapeutic strategy.

More Related Videos

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.6K
Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
09:44

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing

Published on: December 23, 2022

2.4K

Related Experiment Videos

Last Updated: Sep 16, 2025

Detection of the pH-dependent Activity of Escherichia coli Chaperone HdeB In Vitro and In Vivo
08:32

Detection of the pH-dependent Activity of Escherichia coli Chaperone HdeB In Vitro and In Vivo

Published on: October 23, 2016

10.7K
The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.6K
Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
09:44

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing

Published on: December 23, 2022

2.4K

Area of Science:

  • Microbiology
  • Structural Biology
  • Protein Design

Background:

  • Bacteria require iron for growth, and pathogens often acquire it via heme uptake.
  • Pathogenic E. coli and Shigella use the outer membrane transporter ChuA to extract heme from host hemoglobin.
  • Understanding ChuA's heme extraction mechanism is crucial for developing novel antibacterial strategies.

Purpose of the Study:

  • To elucidate the mechanism of heme extraction by the ChuA transporter.
  • To design and develop AI-generated protein binders that inhibit ChuA function.
  • To assess the efficacy of these binders in inhibiting bacterial growth.

Main Methods:

  • Utilized structural modeling, Cryo-EM, X-ray crystallography, and mutagenesis to study ChuA.
  • Employed artificial intelligence-based protein design to create novel inhibitors.
  • Screened designed binders for their ability to inhibit E. coli growth and determined complex structures.

Main Results:

  • Characterized the dynamic heme extraction process by ChuA.
  • Identified AI-designed protein binders that inhibit E. coli growth at low nanomolar concentrations.
  • Confirmed the structural integrity and binding of designed inhibitors to ChuA.

Conclusions:

  • Demonstrated the effectiveness of de novo-designed proteins in inhibiting bacterial nutrient uptake.
  • Established a workflow for targeting integral membrane proteins with designed binders.
  • Highlighted the potential of AI-driven protein design for developing new antibacterial therapeutics.